Covariate-adjusted non-parametric survival curve estimation

Statistics in Medicine

Volumn 30, Issue 11, 2011, Pages 1243-1253

  Jiang, Honghua ^a   Symanowski, James ^b   Qu, Yongming ^a   Ni, Xiao ^a   Wang, Yanping ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NEVADA CANCER INSTITUTE   (United States)

Author keywords

Cox model; Power; Time to event

Indexed keywords

CISPLATIN; PEMETREXED; PLACEBO;

ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER SIMULATION; COVARIATE ADJUSTED NON PARAMETRIC SURVIVAL CURVE ESTIMATION; HUMAN; KAPLAN MEIER METHOD; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; METHODOLOGY; ONCOLOGY; PLEURA MESOTHELIOMA; PROPORTIONAL HAZARDS MODEL; STUDY DESIGN; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; GLUTAMATES; GUANINE; HUMANS; KAPLAN-MEIER ESTIMATE; MESOTHELIOMA; MODELS, STATISTICAL; PLEURAL NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 79955616325     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4216     Document Type: Article

References (20)

1. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457-481.
2. Buyse ME. Analysis of clinical trial outcomes: some comments on subgroup analyses. Controlled Clinical Trials 1989; 10:187S-194S.
3. Gail MH, Wieand S, Piantadosi S. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 1984; 71:431-444.
4. Robinson LD, Jewell NP. Some surprising results about covariate adjustment in logistic regression models. International Statistical Review 1991; 58:227-240.
5. Chastang C, Byar D, Piantadosi S. A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models. Statistics in Medicine 1988; 7:1243-1255.
6. Koch GG, Tangen CM, Jung JW, Amara IA. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. Statistics in Medicine 1998; 17:1863-1892.
7. Ford I, Norrie J. The role of covariates in estimating treatment effects and risk in long-term clinical trials. Statistics in Medicine 2002; 21:2899-2908.
8. Pocock S, Assmann S, Enos L, Kasten L. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Statistics in Medicine 2002; 21:2917-2930.
9. Moore KL, van der Laan MJ. Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation. Statistics in Medicine 2009; 28(1):39-64.
10. Moore KL, van der Laan MJ. Increasing power in randomized trials with right censored outcomes through covariate adjustment. Journal of Biopharmaceutical Statistics 2009; 19(1):1099-1131.
11. Jiang H, Symanowski J, Paul S, Qu Y, Zagar A, Hong S. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates-a simulation study. Statistics in Medicine 2008; 27:5850-5860.
12. Cox DR. Regression models and life tables. Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
13. Tangen CM, Koch GG. Non-parametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial. Journal of Biopharmaceutical Statistics 1999; 9:307-338.
14. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. Journal of Clinical Oncology 2003; 21:2636-2644.
15. Symanowski J, Rusthoven J, Nguyen B, Ruffie P, Moro Sibilot D, Dabouis G, Perol M, Price A, Vogelzang N. Multiple regression analysis of prognostic variables for survival from the phase III study of pemetrexed + cisplatin vs. cisplatin in malignant pleural mesothelioma. Proceedings of the American Society for Clinical Oncology 2003; 22, abstr 2602.
16. SAS Institute, Inc.: SAS/STAT User's Guide, Version 8, Cary, NC, 1999.
17. Breslow N. Disussion of 'Regression Models and Life-Tables' by Cox DR. Journal of the Royal Statistical Society, Series B 1972; 34:216-217.
18. Koch GG, Amara IA, Davis GW, Gillings DB. A review of some statistical methods for covariance analysis of categorical data. Biometrics 1982; 38:563-595.
19. Kock GG. A linear models approach to the analysis of survival and extent of disease in multidimensional contingency tables. Journal of the American Statistical Association 1972; 67:783-796.
20. Moodie PF, Saville BR, Koch GG, Tangen CM. Estimating covariate-adjusted log hazard ratios for multiple time intervals in clinical trials using nonparametric randomization based ANCOVA. Statistics in Biopharmaceutical Research 2011; DOI: 10.1198/sbr.2010.10006.